Myomo Inc.

Cambridge-based medical robotics company commercializing the MyoPro powered arm orthosis for stroke and neurological injury patients using EMG-driven control.

Visit Website

Company Overview

Myomo Inc. is a commercial-stage medical device and medical robotics company headquartered in Burlington, Massachusetts (relocated from Cambridge in late 2024), specializing in myoelectric-controlled upper-extremity powered orthoses. The company was incorporated in Delaware on September 1, 2004, based on technology developed at MIT and Harvard Medical School.

Myomo's flagship product is the MyoPro, a custom-fabricated powered arm brace (limb orthosis) that detects faint myoelectric (EMG) signals from residual muscle activity in a patient's arm and uses motor-driven support to enable functional movement. The MyoPro is designed for patients with upper-limb paralysis or weakness caused by stroke, brachial plexus injury, spinal cord injury, ALS, multiple sclerosis, and other neuromuscular conditions. The device weighs approximately 1.1–1.5 kg depending on configuration and can provide approximately 7 Newton-meters of elbow torque.

The MyoPro 2 and MyoPro 2+ are FDA-cleared as Class II medical devices (powered limb orthosis with biofeedback, 510(k)-exempt category). Myomo obtained CE Mark approval for commercial distribution across the European Economic Area and holds a Medical Device Licence from Health Canada. These regulatory clearances make the MyoPro the only commercially available, non-invasive, myoelectrically controlled powered arm brace in its class.

Myomo trades on the NYSE American exchange under the ticker symbol MYO. The company manufactures and fits devices through a network of certified orthotists and clinical professionals across the United States and internationally. In August 2024, Myomo signed a lease for approximately 36,208 square feet of new headquarters and manufacturing space in Burlington, Massachusetts, consolidating its corporate and production operations.

Myomo's clinical evidence includes multiple peer-reviewed studies and a significant body of real-world use data documenting functional gains in Activities of Daily Living (ADL) for chronic stroke survivors and other neurological patients. The company has been featured by Burke Neurological Institute (Weill Cornell Medicine) as a clinical partner and is reimbursed under Medicare and certain commercial insurance plans in the United States.

Capabilities & Activities

Primary type & automation activities this supplier delivers:

Applications & Industries

Product Categories

Products & Solutions

MyoPro 2 Plus

Custom-fabricated powered arm orthosis using EMG signals to restore elbow and hand function for stroke and neurological injury patients.

Partnership & Notable clients

Associating Events

Listed in RobotToday Supplier Discovery. Verified Profile

More related news

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
    Suzy Teele’s Mission at ARM Institute RobotToday  · Oct 13, 2026

Contact Myomo Inc.

WEBSITE

https://myomo.com

EMAIL

[email protected]

PHONE

+1 877 736 9666

HEADQUARTERS

45 Blue Sky Dr
Suite 101
Burlington , Vermont  05401

United States

Company Facts

Founded

2004

Primary Role

Manufacturer

Company Size

-

Primary Region

North America

Annual Sales

-

Funding Stage

-

Funding Total

-